Hannah Swayze

BSc, PhD

Senior Trials Manager

I am a Senior Trial Manager overseeing a portfolio of studies. Previously, I was the Trial Manager for the INVICTUS study, which investigated a novel vaccine in addition to the licensed flu vaccine, to better protects older adults from flu-like illness.

I joined the department in August 2015 as part of the Cardiovascular and Renal Research Theme, where I worked on various CTIMPs.

Prior to working at the PC-CTU I worked as a Postdoctoral Research Fellow at the University of Sussex and Kings College London, on various research projects in the areas of addiction, anxiety, nicotine and attention, and obesity.

Recent publications

Platform Randomised trial of INterventions against COVID-19 in older peoPLE (PRINCIPLE): Protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk
Journal article

Hayward G. et al, (2021), BMJ Open, 11
Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial
Journal article

PRINCIPLE Collaborative Group None. et al, (2021)
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Journal article

Butler CC. et al, (2021), The Lancet, 397, 1063 - 1074
A phase IIb study to determine the safety and efficacy of candidate INfluenza Vaccine MVA-NP+M1 in combination with licensed Ina CTivated infl Uenza vaccine in adult S aged 65 years and above (INVICTUS): a study protocol.
Journal article

Swayze H. et al, (2019), F1000Research, 8
A phase IIb study to determine the safety and efficacy of candidate influenza vaccine MVA-NP+M1 in combination with licensed inactivated influenza vaccine in adultS aged 65 years and above (INVICTUS): A study protocol [version 1; peer review: 1 approved with reservations]
Journal article

Swayze H. et al, (2019), F1000Research, 8
Cocaine effects on mouse incentive-learning and human addiction are linked to α2 subunit-containing GABAA receptors
Journal article

Dixon CI. et al, (2010), Proceedings of the National Academy of Sciences, 107, 2289 - 2294
The duration of nicotine-induced attentional enhancement in the five-choice serial reaction time task: lack of long-lasting cognitive improvement
Journal article

Stolerman IP. et al, (2009), Behavioural Pharmacology, 20, 742 - 754
α1- and α2-containing GABA A receptor modulation is not necessary for benzodiazepine-induced hyperphagia
Journal article

Morris HV. et al, (2009), Appetite, 52, 675 - 683
Alpha2-containing GABAA receptors are involved in mediating stimulant effects of cocaine
Journal article

Morris HV. et al, (2008), Pharmacology Biochemistry and Behavior, 90, 9 - 18

More publications